Daihn Woo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daihn Woo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Da Hyun Lee
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
1 shared publication - Daewon Lee
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
1 shared publication - Eunju Yoon
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea
1 shared publication - Hansaem Jang
Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea
1 shared publication - Jongkyeong Chung
Institute of Molecular Biology and Genetics, Seoul National University, Seoul 08826, Republic of Korea
1 shared publication - Kunwoo Lee
School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 11 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-22
Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila
Diabetic sensory neuropathy (DSN) is one of the most common complications of type 2 diabetes (T2D), however the molecular mechanistic association between T2D and DSN remains elusive. Here we identify ubiquitin C-terminal hydrolase L1 (UCHL1), a deubiquitinase highly expressed in neurons, as a key molecule underlying T2D and DSN. Genetic ablation of UCHL1 leads to neuronal insulin resistance and T2D-related symptoms in Drosophila. Furthermore, loss of UCHL1 induces DSN-like phenotypes, including numbness to external noxious stimuli and axonal degeneration of sensory neurons in flies’ legs. Conversely, UCHL1 overexpression improves DSN-like defects of T2D model flies. UCHL1 governs insulin signaling by deubiquitinating insulin receptor substrate 1 (IRS1) and antagonizes an E3 ligase of IRS1, Cullin 1 (CUL1). Consistent with these results, genetic and pharmacological suppression of CUL1 activity rescues T2D- and DSN-associated phenotypes. Therefore, our findings suggest a complete set of genetic factors explaining T2D and DSN, together with potential remedies for the diseases.
- 11 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-22
Open AccessDiabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila
Diabetic sensory neuropathy (DSN) is one of the most common complications of type 2 diabetes (T2D), however the molecular mechanistic association between T2D and DSN remains elusive. Here we identify ubiquitin C-terminal hydrolase L1 (UCHL1), a deubiquitinase highly expressed in neurons, as a key molecule underlying T2D and DSN. Genetic ablation of UCHL1 leads to neuronal insulin resistance and T2D-related symptoms in Drosophila. Furthermore, loss of UCHL1 induces DSN-like phenotypes, including numbness to external noxious stimuli and axonal degeneration of sensory neurons in flies’ legs. Conversely, UCHL1 overexpression improves DSN-like defects of T2D model flies. UCHL1 governs insulin signaling by deubiquitinating insulin receptor substrate 1 (IRS1) and antagonizes an E3 ligase of IRS1, Cullin 1 (CUL1). Consistent with these results, genetic and pharmacological suppression of CUL1 activity rescues T2D- and DSN-associated phenotypes. Therefore, our findings suggest a complete set of genetic factors explaining T2D and DSN, together with potential remedies for the diseases.